Bayer (ETR:BAYN) Rating Upgrade

Deutsche Bank AG has boosted Bayer (ETR:BAYN) stock to Buy in analysts report revealed to clients and investors on Friday, 26 February, and has set a 12-month price target at EUR 140.00. This target is 42.71 % from BAYN’s last price.

The stock upgrade is well received by investors, as ETR:BAYN is at the moment trading 2.54% higher at EUR 97.83 as of 21:33 Frankfurt time. Bayer shares have dropped -29.31% over the past 200 days, while the Standard & Poor’s 500 index has dropped -7.20% in the same time.

Out of 28 analysts covering Bayer, 16 rate it a Buy, 12 indicate a Hold while 3 suggest a Sell. The highest target is EUR 166.17 and the lowest is EUR 109.32 according to Thomson/First Call. The 12-month mean target is EUR 141.42, which means upside potential of 44.56% over the current price.

ETR:BAYN Price Chart & Trend

The stock price of Bayer has declined 29.31% over the last 200 days, and is in strong down trend. In the last 50 and 100 days, Bayer is down 17.71% and down 14.39%, respectively. Our stocks momentum model is shown on the price chart below.

Source: RightEdge Systems, Yahoo Split & Dividend Adjusted Data and OctaFinance Trading Models

Bayer (ETR:BAYN) Profile

Bayer AG is a Germany-based chemical and pharmaceutical company. The Company’s business operations are organized into three segments: Bayer HealthCare, Bayer CropScience and Bayer MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare researches, develops, manufactures and markets products to improve the health of people and animals.

Bayer (ETR:BAYN) traded up 2.54% on 26 February, hitting EUR 97.83. A total of 3.72 million shares of the company’s stock traded hands. This is up from average of 2.90 million shares. Bayer has a 52 week low of EUR 91.89 and a 52 week high of EUR 146.45. The company has a market cap of 80.90 billion EUR and a P/E ratio of 22.21.

Get the latest Bayer (ETR:BAYN) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Frankfurt: Bayer (ETR:BAYN) Rating Increased to Buy by Deutsche Bank AG with EUR 140.00 Target appeared first on Octafinance.